3GHF | pdb_00003ghf

Crystal structure of the septum site-determining protein minC from Salmonella typhimurium

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2 Family	Cell-division inhibitor MinC, N-terminal domain	8046958	4003351	SCOP2 (2022-06-29)
A	SCOP2 Superfamily	Cell-division inhibitor MinC, N-terminal domain	8103659	3000667	SCOP2 (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	MinC_N	e3ghfA1	A: a/b three-layered sandwiches	X: Cell-division inhibitor MinC, N-terminal domain (From Topology)	H: Cell-division inhibitor MinC, N-terminal domain (From Topology)	T: Cell-division inhibitor MinC, N-terminal domain	F: MinC_N	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	3.30.70.260	Alpha Beta	2-Layer Sandwich	Alpha-Beta Plaits	ACT domain	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF05209	Septum formation inhibitor MinC, N-terminal domain (MinC_N)	Septum formation inhibitor MinC, N-terminal domain	In Escherichia coli Swiss:P06138 assembles into a Z ring at midcell while assembly at polar sites is prevented by the min system. MinC Swiss:P18196 a component of this system, is an inhibitor of FtsZ assembly that is positioned within the cell by int ...	In Escherichia coli Swiss:P06138 assembles into a Z ring at midcell while assembly at polar sites is prevented by the min system. MinC Swiss:P18196 a component of this system, is an inhibitor of FtsZ assembly that is positioned within the cell by interaction with MinDE. MinC is an oligomer, probably a dimer [1]. The C terminal half of MinC is the most conserved and interacts with MinD. The N terminal half is thought to interact with FtsZ.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Septum site-determining protein minC	-	regulation of biological process regulation of cellular process biological regulation cellular process cell division regulation of cell division cell septum assembly cytokinesis cellular component biogenesis cellular component organization cellular component assembly cytokinetic process division septum assembly cell cycle regulation of biological process regulation of cellular process biological regulation cellular process cell division regulation of cell division cell septum assembly cytokinesis cellular component biogenesis cellular component organization cellular component assembly cytokinetic process division septum assembly cell cycle cellular component organization or biogenesis cell cycle process regulation of cellular component organization regulation of cell cycle process regulation of cytokinetic process regulation of cellular component biogenesis regulation of cell septum assembly regulation of cell cycle developmental process anatomical structure morphogenesis anatomical structure development cell morphogenesis	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR005526	Septum formation inhibitor MinC, C-terminal	Domain
A	IPR016098	Cyclase-associated protein CAP/septum formation inhibitor MinC, C-terminal	Homologous Superfamily
A	IPR007874	Septum formation inhibitor MinC, N-terminal	Domain
A	IPR036145	Septum formation inhibitor MinC, C-terminal domain superfamily	Homologous Superfamily
A	IPR013033	Septum formation inhibitor MinC	Family

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.